Real estate has constantly been in the news, so we invited Don Miller, CFA, CEO of Piedmont Office Realty Trust — one of the 10 largest publicly traded office REITs in the United States — to discuss the nature of a real estate investment trust with us.
Robert Stammers, CFA, is director of Investor Engagement for CFA Institute and is responsible for increasing the use and distribution of Future of Finance and CFA Institute content by various audiences. Prior to joining CFA Institute, Stammers was the principal for his founded company where he consulted for real estate owners, lenders, and syndicators to develop and analyze structured real estate investments. There he devised strategy for obtaining debt and preferred equity capital and created finance-related marketing materials and research papers for various clients. Stammers has authored over 100 articles on various financial and investment topics for such investment periodicals as Forbes and Investopedia. He served as a senior equity analyst, where he was responsible for the creation of new investment tools and instructional products to provide the revenues for two new investment education companies. As a senior executive for several institutional fund managers, Stammers was the portfolio manager for a $1 billion enhanced real estate fund, a $1.2 billion private timber fund, and several pension fund separate accounts.
Subscribe to Enterprising Investor and receive the weekly email newsletter.
The Bank of England will not resort to printing money to lessen the economic impact of the coronavirus pandemic, Governor Andrew Bailey says. "Using monetary financing would damage credibility on controlling inflation by eroding operational independence," Bailey says. Reuters (05 Apr.)
Securities and Exchange Commission member Allison Herren Lee wants the agency to pause pending rule changes but not rush into regulatory relief without analysis amid the coronavirus pandemic. "Relevant considerations in that analysis include whether an action is directly responsive to COVID-19 and whether an action represents an appropriate use of agency resources at a time when we are routinely called upon to take emergency actions," she says. Reuters (04 Apr.)
If the US has any shortage of drugs, it is because of high demand and not because China or any other country is preventing the supply of ingredients, says Stephen Hahn, head of the US Food and Drug Administration. "We don't have any evidence that there is a drug in short supply because of anyone blocking the active pharmaceutical ingredients in the drugs," he says. BNN Bloomberg (Canada) (05 Apr.)
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.